Search
Search
About
Log in
Join
Experiences with
Sofosbuvir / Velpatasvir
Posts
Communities
33 public posts
Filter results
Your role in hepatitis C treatment
While it’s encouraging that a new class of prescription medications can cure hepatitis C, the high prices of the drugs are creating a quandary for healthcare stakeholders. The first new drug, sofosbuvir, earned FDA approval in late 2013 and carried a price tag of $84,000 for a course of treatment. “
While it’s encouraging that a new class of prescription medications can cure hepatitis C, the high prices of the drugs are creating a quandary for healthcare stakeholders. The first new drug, sofosbuvir, earned FDA approval in late 2013 and carried a price tag of $84,000 for a course of treatment. “
kcohen
in
HFI Connect - Hepatitis
9 years ago
State restrictions for hepatitis C drug may go too far
(Reuters Health) - State-run insurance programs for the poor may be putting up illegal barriers that prevent people with hepatitis C from getting a new treatment, a new study suggests. "We had this idea that there were restrictions in place, but we didn't anticipate the breadth of these restrictions
(Reuters Health) - State-run insurance programs for the poor may be putting up illegal barriers that prevent people with hepatitis C from getting a new treatment, a new study suggests. "We had this idea that there were restrictions in place, but we didn't anticipate the breadth of these restrictions
kcohen
in
HFI Connect - Hepatitis
9 years ago
State restrictions for hepatitis C drug may go too far
(Reuters Health) - State-run insurance programs for the poor may be putting up illegal barriers that prevent people with hepatitis C from getting a new treatment, a new study suggests. "We had this idea that there were restrictions in place, but we didn't anticipate the breadth of these restrictions
(Reuters Health) - State-run insurance programs for the poor may be putting up illegal barriers that prevent people with hepatitis C from getting a new treatment, a new study suggests. "We had this idea that there were restrictions in place, but we didn't anticipate the breadth of these restrictions
kcohen
in
HFI Connect - Hepatitis
9 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
WHO Adds New Hepatitis C Drugs to Essential Medicines List
The World Health Organization (WHO) has added five hepatitis C virus (HCV) drugs to its essential medicines list in an attempt to improve access to the expensive new treatments across the globe, according to a WHO press release. Inclusion on the list, which the WHO considers “the minimum medicine
The World Health Organization (WHO) has added five hepatitis C virus (HCV) drugs to its essential medicines list in an attempt to improve access to the expensive new treatments across the globe, according to a WHO press release. Inclusion on the list, which the WHO considers “the minimum medicine
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Patent for hepatitis C treatment would cut access for millions, groups say:
Activists charged the pharmaceutical company Gilead on Wednesday of seeking unjustified patents for a hepatitis C medication that would make the treatment prohibitively expensive for millions worldwide. The Initiative for Medicines, Access and Knowledge (I-MAK), a legal advocacy group, announced patent
Activists charged the pharmaceutical company Gilead on Wednesday of seeking unjustified patents for a hepatitis C medication that would make the treatment prohibitively expensive for millions worldwide. The Initiative for Medicines, Access and Knowledge (I-MAK), a legal advocacy group, announced patent
mwright
in
HFI Connect - Hepatitis
9 years ago
Sofosbuvir/Daclatasvir Combination Effective in Hepatitis C Treatment - See more at: http://www.specialtypharmacytimes.com/news/Sofosbuvir-D
he combination of sofosbuvir and daclatasvir showed promising results for the treatment of hepatitis C virus (HCV) during a recent clinical trial, which was the first to evaluate this drug combination in a real world setting. - See more at: http://www.specialtypharmacytimes.com/news/Sofosbuvir-Daclatasvir-Combination-Effective-in-Hepatitis-C-Treatment
he combination of sofosbuvir and daclatasvir showed promising results for the treatment of hepatitis C virus (HCV) during a recent clinical trial, which was the first to evaluate this drug combination in a real world setting. - See more at: http://www.specialtypharmacytimes.com/news/Sofosbuvir-Daclatasvir-Combination-Effective-in-Hepatitis-C-Treatment
mwright
in
HFI Connect - Hepatitis
9 years ago
Adverse side effects on Sofosbuvir and Ribavarin
Was wondering if anyone has had serious adverse side effects on Sofosbuvir and Ribavarin used to treat HepC and what support they had been offered? And also prior to treatment were they fully aware of the side effects? Thanks.
Was wondering if anyone has had serious adverse side effects on Sofosbuvir and Ribavarin used to treat HepC and what support they had been offered? And also prior to treatment were they fully aware of the side effects? Thanks.
cookiecrumbles
in
British Liver Trust
9 years ago
FDA warns of cardiac reactions with Harvoni, Sovaldi drug combinations
The FDA approved the changes to the Harvoni (ledipasvir/sofosbuvir, Gilead Sciences) fixed- dose and Sovaldi (sofosbuvir) labels to update the Warnings and Precautions, Adverse Reactions and Drug Interactions sections, after nine serious cases of symptomatic bradycardia and one fatal cardiac arrest
The FDA approved the changes to the Harvoni (ledipasvir/sofosbuvir, Gilead Sciences) fixed- dose and Sovaldi (sofosbuvir) labels to update the Warnings and Precautions, Adverse Reactions and Drug Interactions sections, after nine serious cases of symptomatic bradycardia and one fatal cardiac arrest
mwright
in
HFI Connect - Hepatitis
9 years ago
Achillion, Gilead drug cocktail cures hepatitis C in six weeks
Achillion achieves 100% SVR12 in six-week regimen with combination of ACH-3102 and sofosbuvir for treatment-naïve genotype 1 HCV - Read more: http://bit.ly/1IEmNKF
Achillion achieves 100% SVR12 in six-week regimen with combination of ACH-3102 and sofosbuvir for treatment-naïve genotype 1 HCV - Read more: http://bit.ly/1IEmNKF
mwright
in
HFI Connect - Hepatitis
10 years ago
Generic drugmakers to produce cheaper version of Sovaldi
Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries. Gilead's agreement also covers another treatment, a single tablet combination of sofosbuvir and another antiviral drug
Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries. Gilead's agreement also covers another treatment, a single tablet combination of sofosbuvir and another antiviral drug
JKArmah
Pioneer
in
HFI Connect - Hepatitis
10 years ago
Update on treatment
As promised... the tablets are called sofosbuvir combined with ledipasvir as well as having ribavirin. so far treatment has been going well, first bloods will be done next week. just a reminder, my husband has liver disease and hep c genotype . will let you know what the results are of the blood
As promised... the tablets are called sofosbuvir combined with ledipasvir as well as having ribavirin. so far treatment has been going well, first bloods will be done next week. just a reminder, my husband has liver disease and hep c genotype . will let you know what the results are of the blood
pear-shaped
in
British Liver Trust
10 years ago
FDA gives its seal of approval to new hep C drug
The first all-oral regimen for treating the hepatitis C virus has been approved by the US FDA. Gilead Science's sofosbuvir was given unanimous backing by the 15 members of the panel. Read our coverage of this treatment development here: http://hepatitiscnews.com/fda-panel-backs-new-hepatitis-c-drug-sofosbuvir
The first all-oral regimen for treating the hepatitis C virus has been approved by the US FDA. Gilead Science's sofosbuvir was given unanimous backing by the 15 members of the panel. Read our coverage of this treatment development here: http://hepatitiscnews.com/fda-panel-backs-new-hepatitis-c-drug-sofosbuvir
Hep_C_News_team
in
Hepatitis C Trust
11 years ago
Congratulation to people with hepatitis c Your CURED !!
(AP) – 1 day ago NEW YORK (AP) — Abbott Laboratories said Monday that its experimental hepatitis C drug regimen cured 99 percent of patients in a midstage study with the most common and hardest-to-treat type of the disease. Patients who took a three-drug regimen and the drugs Ritonavir and ribavirin
(AP) – 1 day ago NEW YORK (AP) — Abbott Laboratories said Monday that its experimental hepatitis C drug regimen cured 99 percent of patients in a midstage study with the most common and hardest-to-treat type of the disease. Patients who took a three-drug regimen and the drugs Ritonavir and ribavirin
Hidden
in
Cure Parkinson's
12 years ago
1
2
Filter results
Clear filters
Posted in
All communities
HFI Connect - Hepatitis
20 results
British Liver Trust
5 results
Hepatitis C Support
4 results
View top 10 communities
Sort by
Most Relevant
Newest